X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

- test

Dr. Sharma Discusses Immunotherapy in Prostate Cancer

Padmanee Sharma, MD, PhD, professor of Immunology in the Department of Genitourinary Medical Oncology at The University of Texas MD... Read More

Expert Emphasizes Inclusivity in Prostate Cancer Trials

African-American patients are at a higher risk of developing and dying from prostate cancer. Additionally, these men are typically diagnosed... Read More

Rethinking the Prostate Cancer Paradigm in the Urology Community

The urology community is deficient in identifying the patient with advanced prostate cancer who is at risk of developing metastatic... Read More

ASCO Adds New Combos for Metastatic Noncastrate Prostate Cancer

Use of androgen deprivation therapy (ADT) in combination with docetaxel (Taxotere) or abiraterone (Zytiga) in newly diagnosed cases of metastatic... Read More

Sequencing Challenges Persist in Metastatic Prostate Cancer

In this interview, Scott Samuelson, MD, explains that there is no definitive evidence to support the use of one agent over... Read More

MRI Combination Techniques Hone Accuracy of Prostate Cancer Diagnosis

Several studies presented at this year’s American Urological Association meeting underscored the value of multiparametric magnetic resonance imaging (mpMRI) in... Read More

Moving Radium-223 Forward in the Treatment Timeline for Prostate Cancer With Bone Metastases

Radium-223 (Xofigo) has efficacy in treating patients with prostate cancer and bone metastases, but is usually introduced into the patient’s... Read More

Study Findings Complicate the Paradigm for Hormone-Sensitive Prostate Cancer

Clinical trial results that challenge the standard of care sometimes make it more difficult for physicians to decide how to... Read More

Expert Discusses Radiation Techniques, Genomic Testing in Prostate Cancer

Since the emergence of new data released in 2017, moderate hypofractionation has proven to be a quicker and efficacious method... Read More

Dr. Den Discusses the Future of Prostate Cancer Research

Watch video.

1 2 3 6